Allspring Global Investments Holdings LLC Raises Stock Position in SIGA Technologies, Inc. (NASDAQ:SIGA)

Allspring Global Investments Holdings LLC grew its position in shares of SIGA Technologies, Inc. (NASDAQ:SIGA) by 172.1% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 211,236 shares of the company’s stock after purchasing an additional 133,597 shares during the period. Allspring Global Investments Holdings LLC owned approximately 0.30% of SIGA Technologies worth $1,426,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the company. DekaBank Deutsche Girozentrale acquired a new stake in shares of SIGA Technologies during the second quarter worth $40,000. Bayesian Capital Management LP purchased a new stake in SIGA Technologies during the first quarter valued at about $97,000. Lazard Asset Management LLC purchased a new position in SIGA Technologies during the 1st quarter worth approximately $105,000. EntryPoint Capital LLC acquired a new position in SIGA Technologies during the first quarter valued at $111,000. Finally, AQR Capital Management LLC purchased a new stake in shares of SIGA Technologies in the second quarter worth approximately $99,000. Institutional investors and hedge funds own 55.40% of the company’s stock.

SIGA Technologies Price Performance

Shares of SIGA stock opened at $7.08 on Thursday. The firm has a market cap of $505.29 million, a P/E ratio of 6.05 and a beta of 0.90. The stock’s 50-day moving average is $7.58 and its two-hundred day moving average is $8.12. SIGA Technologies, Inc. has a fifty-two week low of $4.26 and a fifty-two week high of $12.83.

SIGA Technologies (NASDAQ:SIGA) last posted its quarterly earnings data on Thursday, August 1st. The company reported $0.03 earnings per share for the quarter. The company had revenue of $21.81 million during the quarter. SIGA Technologies had a return on equity of 51.40% and a net margin of 48.55%. During the same period in the prior year, the company posted ($0.04) earnings per share. As a group, research analysts expect that SIGA Technologies, Inc. will post 1.01 EPS for the current year.

About SIGA Technologies

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.